DECLAIR Trademark

Trademark Overview

On Tuesday, July 19, 2011, a trademark application was filed for DECLAIR with the United States Patent and Trademark Office. The USPTO has given the DECLAIR trademark a serial number of 85374939. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 4, 2015. This trademark is owned by Glaxo Group Limited. The DECLAIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
declair

General Information

Serial Number85374939
Word MarkDECLAIR
Filing DateTuesday, July 19, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 4, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 22, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, May 4, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 4, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 26, 2014EXTENSION 5 GRANTED
Friday, August 22, 2014EXTENSION 5 FILED
Friday, August 22, 2014TEAS EXTENSION RECEIVED
Friday, March 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 6, 2014EXTENSION 4 GRANTED
Tuesday, February 25, 2014EXTENSION 4 FILED
Tuesday, February 25, 2014TEAS EXTENSION RECEIVED
Tuesday, September 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2013EXTENSION 3 GRANTED
Thursday, August 29, 2013EXTENSION 3 FILED
Thursday, August 29, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 16, 2013EXTENSION 2 GRANTED
Thursday, February 28, 2013EXTENSION 2 FILED
Thursday, March 14, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 28, 2013TEAS EXTENSION RECEIVED
Saturday, September 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 20, 2012EXTENSION 1 GRANTED
Thursday, September 20, 2012EXTENSION 1 FILED
Thursday, September 20, 2012TEAS EXTENSION RECEIVED
Tuesday, April 3, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 20, 2012EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, December 28, 2011EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 6, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 3, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 3, 2011ASSIGNED TO EXAMINER
Friday, July 22, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 22, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

declair pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological